Low-dose chemotherapy
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Low-dose Chemotherapy is being studied/used in the treatment of cancer to avoid the devastating side effects of conventional chemotherapy. Historically, oncologists have used the highest possible dose that the body can tolerate in order to kill as many cancer cells as possible.[1] After high-dose treatments the body reacts, sometimes quite severely. Unfortunately normal cells, vital organs and the immune system often cannot tolerate the chemo's poisonous assault. Infections from external causes become a leading threat of death.
Some major pharmaceutical companies have spent hundreds of millions of dollars to get FDA approval for drugs to restore cancer patients' immune system.[1]
Forms of low-dose chemotherapy
The following forms of low-dose chemotherapy have been proposed. They are not always widely available treatments at hospitals.
Oral low-dose chemotherapy
Patients are given chemotherapy drugs orally very frequently. This approach can be very effective for some cancer and can minimize side effects for some people. More patients are using oral chemo than ever before.[1][1]
Low-dose chemotherapy and antiangiogenesis
Adam Dicker, M.D., Ph.D., associate professor, Jefferson Medical College of Thomas Jefferson University in Philadelphia, supports that chemotherapy is often used in the highest possible doses. They are rethinking chemotherapy because of the antiangiogenic effects of lowdose chemotherapy given on a more frequent basis than conventional chemo. They have shown excellent antiangiogenic results in the laboratory.[1]
Insulin potentiation therapy low-dose chemotherapy
Although yet to be proven, Insulin potentiation therapy (IPT) proponents suggest that insulin modifies cancer cells receptivity to being penetrated by the chemotherapy. Cancer cells secrete their own insulin and insulin-like growth factor (IGF) which work together to consume your body's nutrients to grow cancer. Cancer cell membranes have about sixteen times more insulin and IGF receptors than normal cells and these receptors react with synthetic insulin. When insulin is administered, the cancer starves for glucose and generates enzyme activity that makes the cell membrane more permeable. The chemotherapy drug gets absorbed by the cancer. By using the very same mechanisms that cancer cells use to grow and kill people, IPT channels the chemotherapy drug directly inside the cancer cells leaving normal cells alone.[1][1]
Insulin therapy is not the same as IPT Low-dose Chemotherapy. Insulin on its own modulates the transportation of nutrients and more throughout the body. There have been several attempts to use insulin in a variety functions that have proven ill advised.
Research
There are many other researchers looking for low-dose chemotherapy treatments.[1][1][1]
Footnotes
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
